• Product NameRopivacaine
• Brief DescriptionInhibitors
• Purification100.00%
• Biological ActivityRopivacaine is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin.
• Target NameSodium Channel inhibitor
• CAS No. 84057-95-4
• Calculated MW 274.4
• Formulation C17H26N2O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C
  Pathways:Membrane transporter/Ion channel
  Receptor:Sodium Channel
  Boling pt:
  Melting pt:144-146C
  Solubility:Water: 57.6 mg/L
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Liu BG, et al. Anesth Analg. 2000 May;90(5):1034-8.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting